Email to a Colleague
Medscape Conference Coverage, based on selected sessions at the:
International Society for Sexual and Impotence Research 11th World Congress (ISSIR)
October 17 - 21, 2004, Buenos Aires, Argentina

This activity is not sanctioned by, nor a part of, the International Society for Sexual and Impotence Research.


Also On This Page:Conference NewsExpert Interview
Topic Overviews
Premature Ejaculation CME
Physicians - up to 0.5 hour(s) of AMA PRA category 1 credit
Current Perspectives on the Treatment of Premature Ejaculation
Wayne J.G. Hellstrom, MD, FACS
The Psychological Effects of Premature Ejaculation and the Need for New Treatment
Andrew R. McCullough, MD
Erectile Dysfunction CME
Physicians - up to 0.5 hour(s) of AMA PRA category 1 credit
Comparative Efficacy and Patient Preferences for PDE-5 Inhibitors
Gregory A. Broderick, MD
Complications of Prostate and Penile Surgery
John P. Mulhall, MD
Female Sexual Dysfunction CME
Physicians - up to 0.75 hour(s) of AMA PRA category 1 credit
Is There Enough Evidence for the Pharmacologic Treatment of Female Sexual Dysfunction?
Alessandra Graziottin, MD
New Research in Female Sexual Dysfunction
Alessandra Graziottin, MD
Daily Commentary
Expert Interview
Diagnosing and Treating Premature Ejaculation: An Expert Interview With Stanley E. Althof, PhD
Medscape talked with Stanley E. Althof, PhD, about the diagnosis and treatment of premature ejaculation.
Conference News
Androgen Insufficiency May Lead to Vulvar Vestibulitis and Genital Pain 10/26/04
[Medscape Medical News]
Decreased androgen receptor expression may lead to vestibular adenitis and dyspareunia.
Penile Injection of Gene Therapy Appears Safe in Men With Erectile Dysfunction 10/25/04
[Medscape Medical News]
In a phase 1 trial, a subtherapeutic dose of the human recombinant Maxi-K gene was not associated with adverse events.
Dapoxetine Appears Well Tolerated, Effective for Premature Ejaculation Disorder 10/20/04
[Medscape Medical News]
A phase 2 trial found that dapoxetine 60 mg improved intravaginal ejaculatory latency time.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the International Society for Sexual and Impotence Research. These materials and the related activity are not sanctioned by the International Society for Sexual and Impotence Research or by Ortho-McNeil and do not constitute an official part of that conference.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2004 Medscape.

 


Ortho Urology

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.